Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
- 14 July 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 16 (8), 957-966
- https://doi.org/10.1016/s1470-2045(15)00004-2
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health National Cancer Institute (R01 Grant CA090559)
This publication has 35 references indexed in Scilit:
- Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomesZeitschrift für Krebsforschung und Klinische Onkologie, 2014
- Interval Between Surgery and Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Does Delayed Surgery Have an Impact on Outcome?International Journal of Radiation Oncology*Biology*Physics, 2008
- Recommendations for the reporting of surgically resected specimens of colorectal carcinomaHuman Pathology, 2007
- Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancerColorectal Disease, 2006
- Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiationAnnals of Oncology, 2006
- The Development of a Validated Instrument to Evaluate Bowel Function After Sphincter-Preserving Surgery for Rectal CancerDiseases of the Colon & Rectum, 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerThe New England Journal of Medicine, 2004
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Adenocarcinoma of the rectum treated by radical external radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- The quality of life after rectal excision for low rectal cancerBritish Journal of Surgery, 1983